Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H Munn

Showing results (11-20 of 185) with videos related to

Pageof 19
Sort By:
Current Opinion in Immunology|November 27, 2015
Immune suppressive mechanisms in the tumor microenvironmentDavid H Munn, Vincenzo Bronte
Cancer Research|June 1, 1993
Cytokine regulation of human monocyte differentiation in vitro: the tumor-cytotoxic phenotype induced by macrophage colony-stimulating factor is developmentally regulated by gamma-interferonD H Munn, E Armstrong
North Carolina Medical Journal|May 6, 2020
Historical Geography and Health Equity: An Exploratory View of North Carolina Slavery and Sociohealth FactorsNicole Dozier, William H Munn
Journal of Reproductive Immunology|October 16, 2001
Tryptophan catabolism prevents maternal T cells from activating lethal anti-fetal immune responsesA L Mellor, D H Munn
Immunology Today|September 29, 1999
Tryptophan catabolism and T-cell tolerance: immunosuppression by starvation?A L Mellor, D H Munn
International Reviews of Immunology|February 15, 2000
Macrophage suppression of T cell activation: a potential mechanism of peripheral toleranceJ T Attwood, D H Munn
Nature Reviews. Immunology|December 8, 2007
Creating immune privilege: active local suppression that benefits friends, but protects foesAndrew L Mellor, David H Munn
Trends in Immunology|February 4, 2016
IDO in the Tumor Microenvironment: Inflammation, Counter-Regulation, and ToleranceDavid H Munn, Andrew L Mellor
Immunological Investigations|September 29, 2012
Host indoleamine 2,3-dioxygenase: contribution to systemic acquired tumor toleranceTheodore S Johnson, David H Munn
Journal of Immunology (Baltimore, Md. : 1950)|June 10, 2003
Tryptophan catabolism and regulation of adaptive immunityAndrew L Mellor, David H Munn
Pageof 19

Showing results (11-20 of 185) with videos related to

Sort By:
Pageof 19
Current Opinion in Immunology|November 27, 2015
Immune suppressive mechanisms in the tumor microenvironmentDavid H Munn, Vincenzo Bronte
Cancer Research|June 1, 1993
Cytokine regulation of human monocyte differentiation in vitro: the tumor-cytotoxic phenotype induced by macrophage colony-stimulating factor is developmentally regulated by gamma-interferonD H Munn, E Armstrong
North Carolina Medical Journal|May 6, 2020
Historical Geography and Health Equity: An Exploratory View of North Carolina Slavery and Sociohealth FactorsNicole Dozier, William H Munn
Journal of Reproductive Immunology|October 16, 2001
Tryptophan catabolism prevents maternal T cells from activating lethal anti-fetal immune responsesA L Mellor, D H Munn
Immunology Today|September 29, 1999
Tryptophan catabolism and T-cell tolerance: immunosuppression by starvation?A L Mellor, D H Munn
International Reviews of Immunology|February 15, 2000
Macrophage suppression of T cell activation: a potential mechanism of peripheral toleranceJ T Attwood, D H Munn
Nature Reviews. Immunology|December 8, 2007
Creating immune privilege: active local suppression that benefits friends, but protects foesAndrew L Mellor, David H Munn
Trends in Immunology|February 4, 2016
IDO in the Tumor Microenvironment: Inflammation, Counter-Regulation, and ToleranceDavid H Munn, Andrew L Mellor
Immunological Investigations|September 29, 2012
Host indoleamine 2,3-dioxygenase: contribution to systemic acquired tumor toleranceTheodore S Johnson, David H Munn
Journal of Immunology (Baltimore, Md. : 1950)|June 10, 2003
Tryptophan catabolism and regulation of adaptive immunityAndrew L Mellor, David H Munn
Pageof 19